Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United KingdomUpdates
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 caution in use-Betamethasone Ointment 0.1% 30g
Manx Healthcare Ltd. has informed MHRA that they have identified a problem with the product packaging of the batch indicated
MHRA Drug alert date: 3rd June 2024
Pip code | Product description | Supplier | Batch Numbers |
8085151 | BETAMETHASONE OINT 0.1% W/W | MANX HEALTHCARE | G0039 |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please contact medinfo@manxhealthcare.com, or telephone: +44 (0)1926 482511.
For stock control enquiries please contact customerservice@manxhealthcare.com, or telephone: +44 (0)1926 482511.
SUB-TYPE:
Alliance Healthcare UK to enter into a new reduced wholesale agreement with AstraZeneca: July 2024
We are pleased to announce that, as of 1 July 2024, Alliance Healthcare UK will become one of the chosen wholesalers to supply selected products of AstraZeneca’s product portfolio to all pharmacies, hospital pharmacies, and doctors in the United Kingdom, including Northern Ireland.
Click here for full product details.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 caution in use-Freeflex Sodium chloride 0.9%
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
MHRA drug alert date: 22nd May 2024
MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-fresenius-kabi-limited-sodium-chloride-0-dot-percent-intravenous-infusion-bp-freeflex-and-freeflex-plus-el-24-a-slash-17
Pip code | Product description | Supplier | Batch Numbers |
8133167 | SODIUM CHLORIDE INF IV 0.9% 500ml | FRESENIUS KABI | 13SKL101 13TAL213 |
Alliance do not stock | SODIUM CHLORIDE INF IV 0.9% 100ml | FRESENIUS KABI | 13SLF242 13TAF173 |
Alliance do not stock | SODIUM CHLORIDE INF IV 0.9% 250ml | FRESENIUS KABI | 13SMF061 13TBF281
|
This is a caution in use only we are not accepting stock returns
Further Information
For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0) 1928 533575.
For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758.
SUB-TYPE: PRESS RELEASES
Visit from the Shadow Roads Minister and PPC for Leigh
On Friday 10 May we hosted a visit from the Shadow Roads Minister, Bill Esterson, and the Labour prospective parliamentary candidate for Leigh, Jo Platt, to Alliance Healthcare’s Leigh Service Centre.
The pair were given a full site tour by Leigh’s service centre manager, Zakir Patel, to showcase the sites capabilities and highlight its important role in delivering medicine to community pharmacists and hospitals in the northwest.
The pair also had the opportunity to meet members of the 280-strong team and get a better understanding of the vital work carried out at our service centre.
We discussed the Labour party’s Net Zero ambitions as well as Alliance Healthcare’s sustainability credentials.
We would like to thank all those involved in the visit and a special thanks to those at the Leigh Service Centre for their continued hard work and dedication to create healthier futures.
SUB-TYPE: CLASS 3 RECALL
UPDATE: Class 3 recall-PI Keppra tablets 500mg
The class 4 caution in use on the below has now progressed to a Class 3 recall
Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V.
MHRA drug alert date: 15th May 2024
Pip code | Product description | Supplier | Batch Numbers |
8093569 | PI KEPPRA TABS 500MG | Doncaster Pharma | SEE ABOVE LINK |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
Further Information
For medical information and stock control enquiries please contact Doncaster Pharma on tel. 01302 365 000, email quality.enquiries@doncasterpharma.co.uk or commercial@doncasterpharma.co.uk
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Caution in use-Trazodone 50mg/ml oral solution
Cygnus Pharma Ltd. Have informed MHRA that the European Article Number (EAN) barcode printed on various packs of Trazodone Hydrochloride 50mg/5ml Oral Solution, is defective and returns the incorrect information
MHRA drug alert date: 22nd May 2024
MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cygnus-pharma-ltd-trazodone-hydrochloride-50mg-slash-5ml-oral-solution-el-24-a-slash-16
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | TRAZODONE SOLN 50MG/5ML | Cygnus Pharma Ltd. | AS240145A AS240146A |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please email info@cygnuspharma.co.uk or telephone 01582 809833.
For stock control enquiries please email info@cygnuspharma.co.uk or telephone 01582 809833.
SUB-TYPE:
Alliance Healthcare Partners with Mercedes-Benz Vans to Raise Awareness for Drivers’ Mental Health
To mark the start of Mental Health Awareness Week (13-19 May) Alliance Healthcare UK, the UK’s leading wholesaler of healthcare products, has partnered with Mercedes-Benz Vans to bring van drivers together through sport.
Mercedes-Benz Vans and ex-Sky Sports football pundit Chris Kamara have launched Vantasy Football, the UK’s first five-a-side football tournament to bring van drivers together to help improve mental wellbeing.
A team of Alliance Healthcare delivery drivers taking part in the tournament joined Kamara for a football coaching session and as an opportunity to open up about driver mental health. The event comes as Mercedes-Benz Vans launched it’s Under the Bonnet report which revealed van drivers spend up to 25 hours a week alone with no one to talk to while a third (35%) have three or fewer conversations a day at work – compared with the national average of 27.
Alliance Healthcare’s 1,300 drivers deliver 2.4 million medicines to pharmacies and healthcare professionals across the UK every day to help ensure patients have access to the medications they need. Beyond the football training event, Alliance Healthcare has planned activities throughout the year to support positive mental health, including its annual football tournament that brings together over 100 players and their families from across the network.
Alliance Healthcare also supports the mental health of its drivers through ongoing education and awareness. The driver booklet ‘A road to wellness’ contains information relating to mental health and signposting to resources for further help and support. Alliance Healthcare provides all team members with access to an employee assistance programme, as well as the internal support (in-house) from 80 trained mental health first aiders.
Marie Evans, Managing Director of Alliance Healthcare UK, said: “Our 1,300 drivers are the backbone of our delivery network, working hard to ensure that pharmacies, healthcare professionals and patients across the UK have access to the medications they need. The campaign with Mercedes-Benz Vans shines an important light on some of the pressures faced by drivers across every industry. The initiative identified that sport, alongside ongoing education and awareness, reflects our continued commitment to support the mental health and wellbeing of our teams. While there’s always more to do, listening and understanding is an important first step and we’re proud to be supporting our drivers with greater resource, including dedicated mental health first aiders, and bringing them together through team sport.”
Antony Simmons, Head of Transport for Alliance Healthcare UK, said: “At Alliance Healthcare UK, we put our people first. On a daily basis as a driver, you face many unique and sometimes stressful situations; I’ve worked in transport for over 30 years and was a driver myself, so I understand the challenges faced by our drivers and the potential for it to become a pressurised and lonely role if you don’t have the support in place. That’s why I’m pleased that Alliance Healthcare UK is shining a light on mental health and proactively taking steps to support the safety, efficiency, and overall wellbeing of our drivers.”
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 caution in use-PI Keppra tablets 500mg
Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V.
MHRA drug alert date: 15th May 2024
Pip code | Product description | Supplier | Batch Numbers |
8093569 | PI KEPPRA TABS 500MG | Doncaster Pharma | SEE ABOVE LINK |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information and stock control enquiries please contact Doncaster Pharma on tel. 01302 365 000, email quality.enquiries@doncasterpharma.co.uk or commercial@doncasterpharma.co.uk
SUB-TYPE:
Spring 2024 Bank Holiday Opening Hours
To help keep our customers informed of changes to our service, we have published our Spring 2024 bank holiday opening hours for pharmacy and retail customers.
Spring 2024 bank holiday opening hours - England, Scotland, Wales and Northern Ireland
Spring 2024 bank holiday opening hours - Channel Islands and Isle of Man
SUB-TYPE: CLASS 3 RECALL
Class 3 recall-Suprefact 1 mg/ml solution for injection
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure. This is because the named batch of Suprefact 1mg/ml solution for injection is being distributed in packaging intended for the Canadian market by Cheplapharm, instead of the correct UK packaging by Neon Healthcare Ltd for Buserelin 1 mg/ml solution for injection.
Pip code | Product description | Supplier | Batch Numbers |
0308429 | SUPREFACT VIAL | Neon Healthcare LTD | 3F022A |
Further Information
For medical information or stock control enquiries please contact: Neon Healthcare Ltd via Medinfo@neonhealthcare.com or +44 (0) 1992 926 330
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.